The Nor-Hand Study
1 other identifier
observational
300
1 country
1
Brief Summary
The Nor-Hand study is a hospital-based observational study including 300 patients with evidence of hand OA by ultrasound and/or clinical examination. The baseline examination (2016-17) consists of functional tests and joint assessment of the hands, medical assessment, pain sensitization tests, ultrasound (hands, acromioclavicular joint, hips, knees and feet), computer tomography (CT) and Magnetic Resonance Imaging (MRI) of the dominant hand, conventional radiographs of the hands and feet, fluorescence optical imaging of the hands, collection of blood and urine samples as well as self-reported demographic factors and OA-related questionnaires. Two follow-up examinations are planned after 3 (2019-20) and 8 years (2024-25), respectively. Cross-sectional analyses will be used to investigate agreements and associations between different relevant measures at the baseline examination, whereas the longitudinal data will be used for evaluation of predictors for clinical outcomes and disease progression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 8, 2017
CompletedFirst Posted
Study publicly available on registry
March 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedSeptember 19, 2025
September 1, 2025
5.1 years
March 8, 2017
September 18, 2025
Conditions
Outcome Measures
Primary Outcomes (73)
Demographic factors
Self-reported relationship status, education, employment, hand tasks in work/previous work, birth place
Baseline
Demographic factors
Self-reported relationship status, social network, education, employment
3 year follow-up
Life style factors
Self-reported physical activity, smoking, use of alcohol (AUDIT-C)
Baseline
Life style factors
Self-reported physical activity, smoking, use of alcohol (AUDIT-C)
3 year follow-up
Clinical disease variables
Self-reported year diagnosed with OA, number of years with OA symptoms, OA in family, previous injuries of hand/foot, use of medications, previous steroid injections, use of hand orthoses, use of customized tools, previous surgeries, use of alternative therapies, use of supplements, use of nature cures, use of self-help techniques
Baseline
Clinical disease variables
Previous injuries of hand/foot, use of medications, previous steroid injections, use of hand orthoses, use of customized tools, previous surgeries, use of alternative therapies, use of supplements, use of nature cures, use of self-help techniques
3 year follow-up
EuroQol 5 dimensions
Self-reported mobility, self-care, usual activity, pain/discomfort, anxiety/depression
Baseline
EuroQol 5 dimensions
Self-reported mobility, self-care, usual activity, pain/discomfort, anxiety/depression
3 year follow-up
Sleep disturbances
Self-reported sleep disturbances
Baseline
Sleep disturbances
Self-reported sleep disturbances
3 year follow-up
Michigan Hand Outcomes Questionnaire (MHOQ)
Aesthetic damage subscale
Baseline
Michigan Hand Outcomes Questionnaire (MHOQ)
All subscales
3 year follow-up
Localization of joint pain (homonculus)
Self-reported pain during the last 24 hours and previous 6 weeks
Baseline
Localization of joint pain (homonculus)
Self-reported pain during the last 24 hours and previous 6 weeks
3 year follow-up
Self-reported joint pain, hand pain, feet pain, fatigue, disease activity
Numeric Rating Scale (0-10)
Baseline
Self-reported joint pain, hand pain, feet pain, fatigue, disease activity
Numeric Rating Scale (0-10)
3 year follow-up
Australian/Canadian hand index (AUSCAN)
Self-reported hand pain, stiffness and physical function
Baseline
Australian/Canadian hand index (AUSCAN)
Self-reported hand pain, stiffness and physical function
3 year follow-up
Western Ontario and McMaster Universities Arthrtis Index (WOMAC)
Self-reported knee/hip pain, stiffness and physical function
Baseline
Western Ontario and McMaster Universities Arthrtis Index (WOMAC)
Self-reported knee/hip pain, stiffness and physical function
3 year follow-up
Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)
Modified version to assess constant and intermittent pain in patients with hand OA (self-reported)
Baseline
McGill Questionnaire
Modified version to assess hand OA pain characteristics (self-reported)
Baseline
PainDetect
Modified version to assess neuropathic hand pain (self-reported)
Baseline
PainDetect
Modified version to assess neuropathic hand pain (self-reported)
3 year follow-up
Brief Approach/Avoidance Coping Questionnaire (BACQ)
Self-reported approach-oriented and avoidance oriented coping
Baseline
Pain catastrophizing scale
Self-reported magnification, rumination, helplessness
Baseline
Pain catastrophizing scale
Self-reported magnification, rumination, helplessness
3 year follow-up
Self-efficacy scales
Self-reported ability influence pain and symptoms
Baseline
Self-efficacy scales
Self-reported ability influence pain and symptoms
3 year follow-up
Foot Function Index
Self-reported pain in feet, disability, activity restrictions
Baseline
Foot Function Index
Self-reported pain in feet, disability, activity restrictions
3 year follow-up
Hormonal factors in women
Menopause
Baseline
Hormonal factors in women
Menarche, menopause, gynecological operations, hormone treatment, pregnancies, breastfeeding
3 year follow-up
Use of shoewear
The use of shoes with varying type of forefoot and heels
3 year follow-up
Global health assessment
The evaluation of the global health on Visual analogue scale (VAS)
3 year follow-up
Pain Sensitivity Questionnaire
Pain in different daily-life situations, normally leading to no or little pain
3 year follow-up
Fibromyalgia symptoms
ACR criteria for fibromyalgia
3 year follow-up
Short form 12 Energy
One question from Short form 12 about poor energy
3 year follow-up
Brief Illness Perception Questionnaire
Illness perception related to their hand OA disease and symptoms
3 year follow-up
Height
Examination of height in standing position (performed by medical student)
Baseline
Height
Examination of height in standing position (performed by medical student)
3 year follow-up
Weight
Examination of weight in light-weighted clothes (performed by medical student)
Baseline
Weight
Examination of weight in light-weighted clothes (performed by medical student)
3 year follow-up
Hip/waist circumference
Examination of hip and waist circumference (performed by medical student)
Baseline
Hip/waist circumference
Examination of hip and waist circumference (performed by medical student)
3 year follow-up
Blood pressure
Examination of blood pressure after rest (performed by medical student)
Baseline
Blood pressure
Examination of blood pressure after rest (performed by medical student)
3 year follow-up
Heart rate
Examination heart rate after rest (performed by medical student)
Baseline
Heart rate
Examination heart rate after rest (performed by medical student)
3 year follow-up
Comorbidity questionnaires and medications
Self-reported comorbidities and medications
Baseline
Comorbidity questionnaires and medications
Self-reported comorbidities and medications
3 year follow-up
Hair sample
Small hair sample is collected from the back of the patients´ head for quantification of cortisol
Baseline
Joint assessment (examination by rheumatologist)
Bony enlargement, tenderness (Doyle index in hand) and soft tissue swelling in hands and feet, and assessment of the ACR criteria of hand, knee and hip
Baseline
Joint assessment (examination by rheumatologist)
Bony enlargement, tenderness (Doyle index in hand) and soft tissue swelling in hands and feet, and assessment of the ACR criteria of hand, knee and hip
3 year follow-up
Grip strength
Bilateral measurement of grip strength using Jamar dynamometer
Baseline, follow-up
Grip strength
Bilateral measurement of grip strength using Jamar dynamometer
3 year follow-up
Moberg Pick-Up test
Bilateral measurement of fine motor acitivities (time to pick up small elements and put in the box)
Baseline
Moberg Pick-Up test
Bilateral measurement of fine motor acitivities (time to pick up small elements and put in the box)
3 year follow-up
Chair Stand test
Number of chair stands during 30 sec
3 year follow-up
40 m walking test
Time in sec for 40 m walking
3 year follow-up
Pain sensitization tests
Temporal summation, pressure pain threshold (painful finger joint, non-painful finger joint, trapezius muscle, left distal radioulnar joint and tibialis anterior muscle), conditioned pain modulation, light touch
Baseline
Pain sensitization tests
Temporal summation, pressure pain threshold (painful finger joint, non-painful finger joint, trapezius muscle, left distal radioulnar joint and tibialis anterior muscle), conditioned pain modulation, light touch
3 year follow-up
Ultrasound examination
Osteophytes, grey-scale synovitis and power doppler activity in hands, AC joint, hips, knees and feet
Baseline
Ultrasound examination
Osteophytes, grey-scale synovitis and power doppler activity in hands, AC joint, hips, knees and feet
3 year follow-up
Fluorescence Optical Imaging
Examination of altered microcirculation in the hands
Baseline
Fluorescence Optical Imaging
Examination of altered microcirculation in the hands
3 year follow-up
Conventional radiographs
Hands (frontal), feet (frontal, oblique and side images)
Baseline
Conventional radiographs
Hands (frontal), feet (frontal, oblique and side images)
3 year follow-up
MRI
MRI of dominant hand
Baseline
MRI
MRI of dominant hand
3 year follow-up
CT
CT of dominant hand
Baseline
Biobank
Collection of whole blood, serum, plasma and urine
Baseline
Biobank
Collection of whole blood, serum, plasma and urine
3 year follow-up
Study Arms (1)
Hand osteoarthritis
Men and women (40-70 years) with a diagnosis of hand OA based on clinical or ultrasound examination are included. Patients with systemic inflammatory joint diseases, psoriasis and hemochromatosis are excluded.
Interventions
Conventional radiographs (hands/feet), CT of dominant hand, MRI of dominant hand, ultrasound (hands/shoulder/feet/hips/knees), fluorescence optical imaging of hands
Joint assessment of hands and feet, pain sensitization test and functional tests
Self-reported demographic factors, clinical variables and OA history and symptoms
Eligibility Criteria
The study population consists of men and women between the ages of 40-70 years. Their diagnosis of hand OA has been proven either by ultrasound and/or clinical examination performed by a rheumatologist at the Rheumatology Outpatient clinic at Diakonhjemmet Hospital. In addition, all patients must be able to sign and understand an informed consent form.
You may qualify if:
- Age between 40-70 years at screening
- Proven hand OA by clinical examination and/or ultrasound
- Clinical examination criteria: Heberden/Bouchards nodes and/or bony enlargement, squaring and/or deformity of the thumb base and no clinical signs of inflammatory arthritis (e.g. soft tissue swelling of two or less metacarpophalangeal (MCP) joints, and no soft tissue swelling of the wrist).
- Ultrasound criteria: Osteophytes in the interphalangeal joints and/or the thumb base, and no signs of inflammatory arthritis (e.g. synovitis with power Doppler activity in two or less MCP joints and no synovitis with power Doppler activity in the wrist).
- Capable of understanding and signing an informed consent form
- Provided a written informed consent to participate in the study
You may not qualify if:
- Diagnosis of inflammatory arthritic disease, e.g. seropositive or seronegative rheumatoid arthritis, psoriatic arthritis, reactive arthritis, spondyloarthritis or arthritis related to connective tissue disorders
- Diagnosis of psoriasis
- Erythrocyte sedimentation rate (ESR) \> 40 mm/hour and/or C-reactive protein (CRP) \>20 mg/L, without a known ongoing infection
- Anti Cyclic Citrullinated Protein (anti-CCP) and/or rheumatoid factor positivity
- Ferritin \>200 microgram/L for women and \>300 microgram/L for men and s-iron/s-total iron binding capacity (TIBC) above 50%
- Major co-morbidities (e.g. severe malignancies, severe diabetes mellitus, severe infections, uncontrollable hypertension, severe cardiovascular disease or severe respiratory disease)
- Mental or psychiatric disorders, alcohol or drug abuse, language difficulties or other factors that make compliance to the study protocol difficult.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Diakonhjemmet Hospital
Oslo, Norway
Related Publications (4)
Fjellstad CM, Mathiessen A, Slatkowsky-Christensen B, Kvien TK, Hammer HB, Haugen IK. Associations Between Ultrasound-Detected Synovitis, Pain, and Function in Interphalangeal and Thumb Base Osteoarthritis: Data From the Nor-Hand Cohort. Arthritis Care Res (Hoboken). 2020 Nov;72(11):1530-1535. doi: 10.1002/acr.24047.
PMID: 31421023DERIVEDGloersen M, Steen Pettersen P, Kvien TK, Haugen IK. Validation of the Intermittent and Constant Osteoarthritis Pain Questionnaire in Patients with Hand Osteoarthritis: Results from the Nor-Hand Study. J Rheumatol. 2019 Jun;46(6):645-651. doi: 10.3899/jrheum.180835. Epub 2019 Mar 15.
PMID: 30877221DERIVEDSteen Pettersen P, Neogi T, Magnusson K, Berner Hammer H, Uhlig T, Kvien TK, Haugen IK. Peripheral and Central Sensitization of Pain in Individuals With Hand Osteoarthritis and Associations With Self-Reported Pain Severity. Arthritis Rheumatol. 2019 Jul;71(7):1070-1077. doi: 10.1002/art.40850. Epub 2019 May 14.
PMID: 30741501DERIVEDGloersen M, Mulrooney E, Mathiessen A, Hammer HB, Slatkowsky-Christensen B, Faraj K, Isaksen T, Neogi T, Kvien TK, Magnusson K, Haugen IK. A hospital-based observational cohort study exploring pain and biomarkers in patients with hand osteoarthritis in Norway: The Nor-Hand protocol. BMJ Open. 2017 Sep 24;7(9):e016938. doi: 10.1136/bmjopen-2017-016938.
PMID: 28947452DERIVED
Biospecimen
Serum, urine, plasma and whole-blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ida K Haugen, MD, PhD
Diakonhjemmet Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
March 8, 2017
First Posted
March 20, 2017
Study Start
April 1, 2016
Primary Completion
May 1, 2021
Study Completion
May 1, 2021
Last Updated
September 19, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share